Jazz Pharma Plc (JAZZ)
$137.62 0.79 (0.58%)
17:50 EST JAZZ Stock Quote Delayed 15 Minutes
Previous Close $137.62
Market Cap 7.97B
PE Ratio 18.85
Volume (Avg. Vol.) 522,200
Day's Range 136.66 - 138.85
52-Week Range 116.52 - 154.24
Dividend & Yield N/A (N/A)
JAZZ Stock Predictions, Articles, and Jazz Pharma Plc News
- From InvestorPlace
- From the Web
These ten growth stocks saw the highest percentage growth over the last decade, and some remain unknown to investors despite huge increases.
Big biotech buyouts have already started happening. These five biotech stocks could be the next to go.
P/B ratio is a convenient tool to identify low-priced stocks that have high-growth prospects. Here are five stocks with low P/B ratios.
These five biotech stocks balance low valuation with high growth and a track record of profits.
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects. Compare Brokers....
Jazz Pharmaceuticals stock is hovering around breakeven after agreeing to acquire Celator (CPXX) for a 73% premium. Does the deal make sense?
Was 2015 the final nail in the coffin for buy-and-hold investing? Not necessarily. Buy these 7 names and hold for 2016 before letting them go
While the rest of the market is enjoying a healthy start to the fall, biopharma stocks continue to lag. Here are 5 pharma stocks on sale now
Jazz Pharmaceuticals, bluebird bio, Illumina and Celgene are the latest batch of biotech stocks worth serious consideration.
By Jeff Reeves
The S&P has roughly doubled in the past five years, but these 10 stocks blow that performance out of the water, with gains of 1,500% or more.
Two of Jazz Pharmaceuticals' drugs are showing record growth, and the stock just keeps making new highs. Can it last?
This week, five Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
Imagine Owning Jazz Pharmaceuticals (NASDAQ:JAZZ) And Wondering If The 20% Share Price Slide Is Justified
From Simply Wall St
Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more than offset the losers At this point some shareholders may<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/imagine-owning-jazz-pharmaceuticals-nasdaqjazz-and-wondering-if-the-20-share-price-slide-is-justified/">Read More...</a></div>
From Market News Video
Investors in Jazz Pharmaceuticals plc (JAZZ) saw new options become available this week, for the September 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 228 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Navellier RatingsPowered by Portfolio Grader